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Background: Diabetes mellitus is a metabolic disease, characterized by hyperglycemia due to disturbance in both insulin 
secretion and function. One of theurapeutic approaches is to reduce blood glucose levels by inhbiting α-/β-glucosidase 
and α-amylase involved in carbohydrate digestion. Thus, inhibition of these enzymes play important role in the treatment 
of diabetes mellitus. Roselle (Hibiscus sabdariffa L.) has been known to have several medicinal properties and potency as 
an antidiabetics agents. This reseacrh aimed to observe antidiabetic properties of roselle ethanol extract (REE) towards 
α-glucosidase, β-glucosidase and α-amylase. 
Materials and Methods: REE was done with maceration technique using diluent of 70% ethanol. Antidiabetic properties 
were measured by inhibitory activity of α-amylase, α-glucosidase and β-glucosidase. 
Results: REE was able to inhibit α-/β-glucosidase and α-amylase in the highest concentration with inhibition percentage of 
72.68, 47.34 and 73.08%  respectively, and were comparable with Acarbose of 81.49, 50.97, 73.08%. The median inhibitory 
concentration (IC50) of α-/β-glucosidase and α-amylase of REE were 15.81, 41.77, 18.09 µg/mL respectively, and Acarbose 
were 9.45, 22.57, 3.64 µg/mL respectively. 
Conclusion: REE inhibits α-/β-glucosidase and α-amylase.
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Introduction
Diabetes mellitus (DM) is a metabolic disease, characterized 
by hyperglycemia due to disturbance in both insulin secretion 
and function.1 Type 1 DM is a type with defective insulin 
secretion by pancreatic β-cells, and type 2 DM is a type with 
insulin resistance (a condition in which peripheral cells do 
not respond normally to insulin) or β-cell dysfunction.2 DM 
has postprandial phase indicated by increased blood glucose 
levels, which is called postprandial hyperglycemia.3
 Antihiperglycemia is commonly used to reduce 
hyperglycemia prostaglandins via inhibition of responsible 
enzymes in glucose absorption that hydrolize carbohydrates, 
such as α-/β-glucosidase and α-amylase.4 Glucosidase is 
an enzyme involved in complex carbohydrate dissociation 
in the small intestine that play its role to cleave glicosidic 
bonds, resulting in glucose release from the non-reducing 
end of an oligo- or poly-saccharide chain involved in 
glycoprotein biosynthesis.4
C e l l  a n d 
B i o p h a r m a c e u t i c a l 
I n s t i t u t e
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 Common drugs are expensive or generate adverse 
effects. Common adverse effects of enzyme-inhibitory 
drugs, like Acarbose, are excessive inhibition of pancreatic 
α-amylase, which can result in abdominal distention, 
flatulence and diarrhea.5 Thus, natural medicine is proposed 
to be an alternative. Traditional herbal medicine is believed 
to possess hypoglycemic activity. There are more than 
800 species of plants reported to contain hypoglycemic 
properties.6
 Roselle (Hibiscus sabdariffa L) has been used as a 
medicinal beverage in many countries such as Australia, 
India, Myanmar, Thailand, Senegal, France, Gambia, 
Nigeria, Greece, Saudi Arabia, Sudan, Latin America, 
Panama, Indonesia, Malaysia and China.7 Bioactive 
compounds is documented in roselle such as alkaloids, 
anthocyanins, flavonoids, saponins, steroids, sterols and 
tannins.8 Roselle extract demonstrate anti-insulin resistance 
properties due to its activity in reducing hyperglycemia 
and hyperinsulinemia, as well as decrease in Low Densisty 
Lipoprotein (LDL) and High Density Lipoprotein (HDL).9 
Roselle extract also play role in lowering blood glucose 
levels in streptozotocin-induced diabetic mice, it is 
comparable with glibenclamide.6,10,11 Therefore our current 
study  was carried out to evaluate possible effectivity of 
Roselle  extract to inhibit α/β-glucosidases and α-amylase.
Materials and methods
Preparation roselle extract
Extraction was performed based on maceration method.12,13 
Roselle calyx were collected from Cimenyan, West Java, 
Indonesia. The plant was identified by herbarium staff 
of Department of Biology, School of Life Sciences and 
Technology, Bandung Institute of Technology, Indonesia. 
Dried and milled roselle calyx were soaked in 70% 
distillated ethanol and filtered every 24 hours. The process 
was performed until colorless filtrate was gained, then 
filtrate was evaporated to obtain ethanol extract. Roselle 
ethanol extract (REE) was stored at -20°C.
α-glucosidase inhibitory activity assay
The α-glucosidase inhibitor  activity  was  tested with 
the modified method.1,14,15 Mixture reaction consists of 
4-Nitrophenyl α-D-glucopyranoside (N1377, Sigma-
Aldrich, St.Louis, USA), phospate buffer (pH 7.0) and 
sample solution. After mixed well, α-glucosidase was added, 
incubated at 37°C for 30 minutes, then Na
2
CO3 was added. 
The 4-Nitrophenyl α-D-glucopyranoside was measured at 
400 nm wavelength with microplate reader The inhibition 
percentage of α-glucosidase was calculated  according to 
equation 1:
% inhibition = (C-S) x 100 
                                                           C
C : absorbance of control
S : absorbance of sample  
β-glucosidase inhibitory activity assay
The β-glucosidase inhibitory activity assay was conducted 
using modified method.1 Mixture solution contained 
4-Nitrophenyl β-D-glucopyranoside (N7006, Sigma-
Aldrich), phosphate buffer (pH 7.0) and sample solution. 
Mixture reaction was incubated at 37°C for 5 minutes, 
added with enzyme mixture and incubated for 15 minutes. 
Reaction was stopped by addition of Na
2
CO3. Absorbance 
of 4-Nitrophenyl β-D-glucopyranoside was measured at 400 
nm wavelength. The inhibition percentage of β-glucosidase 
was calculated according to equation 1.
α-amylase inhibitory activity assay
The α-amylase inhibitory activity assay was performed 
using a modified method.16 Sample was introduced into 
sample well, dimethyl sulfoxide (DMSO) was used as a 
blank. Furthermore, α-amylase enzyme (A7595, Sigma-
Aldrich) was added into each well, except for blank well. 
Then the mixture was incubated at 37°C for 10 minutes, 
and added with starch solution in each well, while control 
well was added with phospate buffer. Another incubation 
at 37°C for 15 minutes was conducted. Enzymatic reaction 
was stopped by adding acidic iodine solution in each well. 
The absorbance  was measured at 565 nm wavelength. The 
inhibition percentage of α-amylase was calculated according 
to equation 1.
Statistical analysis 
Data was presented as mean±standard deviation. To 
compare treatments, analysis of variance (ANOVA) was 
used, and p<0.05 were considered as statistically significant, 
along with Duncan Post-Hoc Test significant and 95% 
confidence interval. The median inhibitory concentration 
(IC50) was measured to determine the inhibitory activies of 
α/β-glucosidase, α-amylase, according to linear regression. 
SPSS version 20.0 program was used for statistical analysis.
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Results
α-glucosidase inhibitory activity
The α-glucosidase inhibitory of REE and Acarbose can be 
seen in Table 1 and Figure 1, and while the value of IC50 can 
be seen in Table 2.
 α-glucosidase activity of REE and Acarbose occurred 
in concentration-dependent manner in which higher 
α-glucosidase inhibition present in higher concentration of 
sample. Figure 1 shows that at the highest concentration 
(37.5 µg/mL), Acarbose generated higher inhibitory 
activity, compared with REE. The IC50 value of Acarbose 
14.65 μM or 9.45 μg/mL was more active than REE 15.81 
μg/mL (Table 2). Inhibition of α-glucosidase is expected to 
normalize blood glucose level.17 Based on statistical analysis, 
both REE and Acarbose had significant α-glucosidase 
inhibition activity differences at each concentration, higher 
concentration increased the  activity (p<0.05).
β-glucosidase inhibitory activity
The β-glucosidase is a carbohydrate hydrolizing enzyme 
associated with metabolic disorder such as DM. Inhibition 
of carbohydrate hydrolyzing enzymes is used as therapeutic 
approach to decrease hyperglucose level and improve 
hyperglicemic.1,18 The β-glucosidase inhibitory of REE 
and Acarbose can be seen in Table 3 and Figure 2, the IC50 
value can be seen in Table 4. The result of β-glucosidase 
activity in REE and Acarbose showed that inhibitory 
activity was associated with concentrations in which higher 
β-glucosidase inhibition present in higher concentration of 
sample. Inhibition percentage of Acarbose with percentage 
50.97±3.78 was comparable with REE 47.34±2.69 (Table 3). 
As shown in Table 4, Acarbose was more active in inhibiting 
β-glucosidase, the IC50 value 34.96 μM or 22.57 µg/mL was 
lower  compared to REE 41.77 µg/mL. Statistical analysis 
showed REE and Acarbose had significant differences in 
β-glucosidases inhibition activity at each concentration, 
higher concentration increased β-glucosidase inhibition 
(p<0.05).
α-amylase inhibitory activity
Pancreatic α-amylase is an enzyme in the digestive 
system and catalyses the initial step in starch hydrolysis.19 
Inhibition of intestinal α-amylase delays the starch and 
oligosaccharides degradation to monosaccharides prior to 
absorbtion, which later decreases the glucose absorption, as 
well as postprandial blood glucose level.20,21 The α-amylase 
activity showed inhibitory activity in concentration-
dependent manner in which increasing concentrations 
generated higher inhibitory activity. Inhibitory activity 
was lower in REE compared to Acarbose (Table 5 & 6, 
Figure 3) with inhibition percentage 73.08±3.85 of REE 
while Acarbose 77.08±4.77. Acarbose was more active in 
inhibiting α-amylase, the IC50 value 5.64 µM or 3.64 µg/mL 
was more active compared to REE 18.09 µg/mL. Based on 
statistical analysis, both REE and Acarbose had significant 
difference in α-amylases inhibition activity at each 
concentration, higher concentration increased  α-amylase 
inhibition  (p<0.05).
Figure 1. The α-glucosidase inhibitory activity  (%) of REE 
and Acarbose. REE and Acarbose were diluted in 10% DMSO to 
reach the final concentrations of  37.5, 12.5, 6.25,  3.125, 1.563, 
0.398, 0.781 μg/mL. 
Table 1. Effect concentrations toward α-glucosidase inhibitory 
activity (%) of REE and Acarbose
The data are presented as mean±standard deviation. Different 
superscript small letters (a,b,c,d,e) indicate significance in the same 
column among concentrations of samples,  used  Duncan’s post 
hoc test at p<0.05. Each treatment of  samples was performed in 
triplicate. 
Concentrations 
(µg/mL or µM) 
Inhibitory Activity (%) 
REE Acarbose 
37.5 72.68±1.56 e 81.49±1.19 e 
12.5 46.38±2.72 d 44.94±0.54 d 
6.25 41.63±0.74 c 38.21±0.32 c 
3.125 38.79±0.26 b 34.86±0.43 a 
1.563 33.16±1.00 a 32.82±0.83 a 
0.781 32.48±1.05 a 32.44±2.82 a 
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Table 3. Effect concentrations toward β-glucosidase inhibitory 
activity (%) of REE and Acarbose
Figure 2. The β-glucosidase inhibitory activity  (%) of REE 
and Acarbose. REE and Acarbose were diluted in 10% DMSO to 
reach the final concentrations of  37.5, 12.5, 6.25,  3.125, 1.563, 
0.398, 0.781 μg/mL. 
The data are presented as mean±standard deviation. Different 
superscript small letters (a,ab,b,bc,c,d,e) indicate significance in the 
same column among concentrations of samples,  used  Duncan’s 
post hoc test at p<0.05. Each treatment of  samples was performed 
in triplicate. 
Concentrations 
(µg/mL or µM) 
Inhibitory Activity 
REE Acarbose 
37.5 47.34±2.69 d 50.97±3.78 e 
12.5 23.47±1.49 c 32.54±3.17 d 
6.25 21.66±0.62 bc 23.81±0.23 c 
3.125 19.56±0.99 ab 22.35±1.06 c 
1.563 16.92±3.32 a 15.60±1.00 b 
0.781 16.39±0.85 a 10.60±1.93 a 
 
Table 2. The median inhibitory activity (IC50) of  α-glucosidase of REE and Acarbose
Sample Equation R2 IC50 
 (µg/mL/μM) 
Average IC50 
(µg/mL/μM) 
REE Test 1 Y = 1.0166x + 33.096 0.9866 16.63 µg/mL  
REE Test 2 Y = 1.0296x + 33.828 0.9845 15.71 µg/mL  
REE Test 3 Y = 1.1288x + 32.976 0.9802 15.08 µg/mL  
Average  y = 1.0584x + 33.3 0.9876 15.77 µg/mL 15.81 ±  0.78 µg/mL 
Acarbose Test 1 Y = 1.3975x + 29.574 0.9977 14.62 μM 
(9.43 µg/mL) 
 
Acarbose Test 2 Y = 1.3267x + 31.097 0.9870 14.25 μM 
(9.43 µg/mL) 
 
Acarbose Test 3 Y = 1.3139x + 30.179 0.9955 15.09 μM 
(9.74 µg/mL) 
 
Average  y = 1.346X + 30.283  0.9961 14.64 μM 
(9.45 µg/mL) 
14.65 ± 0.42 μM 
(9,45 µg/mL) 
 The IC50 value was presented as mean ± standard deviation in each replication of samples (test 1, 2, 
3) and average from 3 replication.
Discussion
The result of present study showed that REE possessed 
antidiabetic activity, based on inhibitory activity of α-/β-
glucosidase and α-amilase. These results indicate the 
antidiabetic properties of REE was lower than Acarbose. 
The α-/β-glucosidase are carbohydrate hydrolyzing 
enzymes that take place in metabolic disorder such as DM. 
Glucosidase cleaves the glycosidic bond that release glucose 
from the non-reducing end of an oligo- or poly-saccharide 
chain involved in glycoprotein biosynthesis.22 Inhibition 
of carbohydrate hydrolyzing enzymes is therefore used as 
therapeutic approach to decrease hyperglycemia.23 This data 
is in accordance with previous study that the aqueous extract 
of roselle has the inhibitory activity of α-glucosidase as well 
as lowering blood glucose levels in DM animal models.24  
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Concentrations 
(µg/mL or µM) 
Inhibitory Activity   
REE Acarbose 
34.29 73.08±3.85 c 77.08±4.77 d 
11.43 41.88±6.45 b 58.82±5.88 c 
5.71 38.00±4.00 b 55.83±3.82 c 
2.86 25.49±3.92 a 52.67±4.16 c 
1.43 22.42±2.78 a 43.86±1.75 b 
0.71 20.24±2.73 a 35.45±0.92 a 
 
Table 5. Effect concentrations toward α-amylase inhibitory 
activity  (%) of REE and Acarbose
Figure 3. The α-amylase inhibitory activity  (%) of REE and 
Acarbose. REE and Acarbose were diluted in 10% DMSO to 
reach the final concentrations of  37.5, 12.5, 6.25,  3.125, 1.563, 
0.398, 0.781 μg/mL.
The data are presented as mean±standard deviation. Different 
superscript small letters (a,b,c,d) indicate significance in the same 
column among concentrations of samples, used Duncan’s post 
hoc test at p<0.05. Each treatment of samples was performed in 
triplicate.
Sample Equation R2 IC50  
(µg/mL/μM) 
Average IC50 
(µg/mL/μM) 
REE Test 1 Y = 0.9265x + 14.298 0.9722 38.53 µg/mL  
REE Test 2 Y = 0.8285x + 15.843 0.9652 41.23 µg/mL  
REE Test 3 Y = 0.7235x + 17.036 0.9944 45.56 µg/mL  
Average  y = 0.8264x + 15.726 0.9864 41.48 µg/mL 41.77 ±  3.55 µg/mL 
Acarbose Test 1 Y = 1.0059x + 16.285 0.9240 33.52  μM 
(21.64 µg/mL) 
 
Acarbose Test 2 Y = 1.0905x + 15.473 0.9075 31.66 μM 
(20.43 µg/mL) 
 
Acarbose Test 3 Y = 0.8627x + 15.738 0.9381 39.71 μM 
(25.63 µg/mL) 
 
Average  y = 0.9864x + 15.832 0.9253 
 
34.63 μM 
(22.35 µg/mL) 
34.96 ± 4.22 μM 
(22.57 µg/mL) 
 
Table 4. The median inhibitory activity (IC50) of  β-glucosidase of REE and Acarbose
The IC50 value was presented as mean ± standard deviation in each replication of samples (test 1, 2, 3) 
and average from 3 replication.
Roselle ethanol extract  reduced  the blood glucose levels 
on diabetic mice was comparable with n-hexane and 
ethyl acetate extract of roselle.6 The ability might be due 
to presence of dietary phytochemicals in roselle such as 
anthocyanins, flavonoids and phenolic acids.25 Roselle also 
has variety content bioflavonoid such as prunin, myrciacitrin, 
6-hydroxyl-flavonoids, 6-hydroxyluteolin, apigenin, and 
luteolin, that can lower blood glucose, and have inhibitory 
activity of α-glucosidase.24 Flavonoid contents of REE are 
flavonols (gossypetin) and the anthocyanins.25 Flavonoid 
and isoflavonoid glycosides are found in human small 
intestine, in which α- and β-glucosidase inhibitory present 
to inhibit carbohydrate catalyses26 that suggests contribution 
of flavonoid content as antidiabetic effects. 
 In this study, REE has α-amylase inhibitory activity. 
Inhibition of α-amylase will promote retardation of starch 
hydrolysis, that reduces digestion and absorption rate 
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Table 6. The median inhibitory activity (IC50) of α-amylase of REE and Acarbose
The IC50 value was presented as mean ± standard deviation in each replication of samples (test 1, 
2, 3) and average from 3 replication.
Sample Equation R2 IC50 
(µg/mL/μM) 
Average IC50 
(µg/mL/μM) 
REE Test 1 Y = 1.5748x + 22.019 0.9858 17.77  µg/mL  
REE Test 2 Y = 1.4414x + 23.607 0.8631 18.31 µg/mL  
REE Test 3 Y = 1.5512x + 22.161 0.9454 18.18 µg/mL  
Average  Y = 1.5158x + 22.596 0.9637 18.07 µg/mL 18.09 ±  0.28 µg/mL 
Acarbose Test 1 Y = 0.8853x + 42.773 0.8291 8.16 µM 
(5.26 µg/mL) 
 
Acarbose Test 2 Y = 1.0349x + 46.243 0.7196 3.63 µM 
2.10 µg/mL 
 
Acarbose Test 3 Y = 1.1141x + 44.305 0.8909 5.11 µM 
(3.29 µg/mL) 
 
Average  Y = 1.0114x + 44.44 0.8308 5.49 µM 
(3.54 µg/mL) 
5.64 ± 2.31 µM 
(3.64 µg/mL) 
 
of carbohydrates, resulting in decreased post-prandial 
hyperglycemia.15 Flavanoids content in roselle play key role 
in α-amylase inhibitory activity.27 Inhibition of α-amylase 
preserve β-cell integrity and function by removing free 
radicals could enhance protection against the progression 
of insulin resistance in type 2 DM.28 Previous studies also 
showed that roselle extract has potency to inhibit α-amylase 
activity, sugars and starch absorption, which may assist in 
weight loss.29
 Flavonoids present in roselle, are well known to 
contain medicinal properties such as antiinflammatory, 
antioxidant and antidiabetic.30,31 Phenolic and flavonoids 
content in roselle are suggested to play role in inhibitory 
activity of both α-amylase and α-/β-glucosidase.32,33 
Interactions between chemical compound of REE and 
enzymes causes alteration in the enzyme’s molecular 
configuration, as well as hydrophilic and hydrophobic 
properties, that will decrease enzyme activities.10 Active 
components of REE compete with the substrate in binding 
to active site of enzyme prevent the oligosaccharides break-
down to disaccharides.34 
Conclusion
REE is a promising antidiabetic agent to inhibit α-/β- 
glucosidase and α-amylase. Further researches regarding 
identification and development of bioactive compounds 
contained in roselle, are encouraged.
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